CD4 and neoplasm: In BALB/c mice immunized with Her2MPtVLP, depletion of both, but not only either CD4+ or CD8+ cells was required to eliminate inhibition of tumour growth, irrespective of whether the anti-CD4 and/or anti-CD8 mAbs were delivered before immunization, or before tumour challenge.